Protect Funding for Cancer Research

[m3032]

As of February 2025, the Administration plans to implement significant budget cuts—exceeding $4 billion annually—to research institutions, including those dedicated to prostate cancer studies. These cuts will have devastating consequences, both immediate and long-term, discouraging young scientists from entering the field and jeopardizing critical advancements in cancer treatment. Further reductions, such as potential cuts to Department of Defense (DOD) cancer research funding—which has been instrumental in breast and prostate cancer breakthroughs—are also likely. We urge you to take action by contacting Congress to oppose these proposed cuts. The member list of the US Congress is: congress.gov/members

What to Say in Your Message:

. Make it Personal: Share your experience with prostate cancer and how research-driven treatments have impacted your life.

. Express Gratitude: Thank your representative for their leadership and support of medical research. Encourage them to continue championing this vital cause.

. A Nonpartisan Issue Prostate cancer knows no political ideologies or geographic boundaries—it affects us all. Together, we can ensure that critical progress in cancer treatment continues. Please write to Congress today.

[j-o-h-n]

AI Overview

Learn more

In 2024, the federal appropriation for the Prostate Cancer Research Program (PCRP) was $110 million. This funding is part of a larger amount, with the National Institutes of Health (NIH) receiving $44.96 billion, including $6.9 billion for the National Cancer Institute (NCI).

The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP. Congress provided further guidance for CDMRP program-level funding, including funding for the Peer Reviewed Cancer Research Program (PRCRP).Apr 1, 2025.

Good Luck, Good Health and Good Humor.

j-o-h-n